Related Experiment Video
Updated: Aug 29, 2025

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
WITHDRAWN: Neoadjuvant Chemotherapy and Bladder-Sparing Surgery for Muscle-Invasive Bladder Cancer: Ten-year Outcomes
1Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Urology
|September 3, 2022
Abstract:
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/ourbusiness/policies/article-withdrawal.

